Clinical Trial Update: Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study of XTL6865 for chronic hepatitis C; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• XTL6865

Snippet

Sponsor: XTL Biopharmaceuticals | Conditions: Hepatitis C | Phase 1 | Status: UNKNOWN